Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   
Gene: Pinlyp (phospholipase A2 inhibitor and LY6/PLAUR domain containing) Rattus norvegicus
Analyze
Symbol: Pinlyp
Name: phospholipase A2 inhibitor and LY6/PLAUR domain containing
Description: Predicted to have phospholipase inhibitor activity. Predicted to be involved in negative regulation of catalytic activity. Predicted to localize to the extracellular region. Orthologous to human PINLYP (phospholipase A2 inhibitor and LY6/PLAUR domain containing); INTERACTS WITH 1,2-dimethylhydrazine; 3,3',5,5'-tetrabromobisphenol A; 3,7-dihydropurine-6-thione.
Type: protein-coding
RefSeq Status: PROVISIONAL
Also known as: hypothetical protein LOC308429; LOC308429; phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein; RGD1565787; similar to RIKEN cDNA 1810065E05; uncharacterized protein LOC308429
Orthologs:
Latest Assembly: Rnor_6.0 - RGSC Genome Assembly v6.0
Position:
Rat AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
Rnor_6.0181,406,632 - 81,412,602 (-)NCBIRnor6.0Rnor_6.0rn6Rnor6.0
Rnor_5.0182,666,950 - 82,673,380 (-)NCBIRnor5.0Rnor_5.0rn5Rnor5.0
RGSC_v3.4179,827,538 - 79,832,891 (-)NCBIRGSC3.4rn4RGSC3.4
Celera174,587,684 - 74,593,037 (-)NCBICelera
Cytogenetic Map1q21NCBI
JBrowse: View Region in Genome Browser (JBrowse)
Model


Disease Annotations
Gene-Chemical Interaction Annotations
Gene Ontology Annotations
References - curated
RGD Disease Portals

Genomics

Comparative Map Data
Position Markers
QTLs in Region (Rnor_6.0)
miRNA Target Status

Sequence

Nucleotide Sequences
Protein Sequences
Transcriptome

Strain Variation

Strain Sequence Variants (Rnor 5.0)

Additional Information

External Database Links
Nomenclature History
 
More on Pinlyp
Alliance Gene
NCBI Gene
Ensembl Gene
JBrowse: rn5 rn6
NCBI Genome Data Viewer

RGD Object Information
RGD ID: 1565787
Created: 2006-02-09
Species: Rattus norvegicus
Last Modified: 2019-04-12
Status: ACTIVE



NHLBI Logo

RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.